in force 2023-08-18
02019R1021-20230610 → 02019R1021-20230818
Amended by Regulation (EU) 2023/866 32023R0866
detected 2026-09-04
1 provision touched — 1 substantive, 0 date-only, 1 disputed · every change carries an explanation that passed its citation check
Emendrix checks every change against three independent sources. Where they disagree it says so rather than picking a winner.
MODIFIED +379 −117 Annex I ANNEX I§
applies from: unknown (the text changed beyond its dates, so no date that moved can be read as the application date)
dates added to the text: 2023-08-18, 2023-08-25 · dates removed: 2022-07-05
Sources disagree — the text comparison and the EU's own amendment metadata found this change; the amending act's instructions do not mention it. All are shown; none is overruled.
In the PFOA entry, point 3's review-and-assessment deadline for the transported isolated intermediate exemption was changed from 5 July 2022 to 25 August 2023.
Point 4 was rewritten: the reference to Article 4(1), point (b) is now expressed differently, an end date of 18 August 2023 was added for the PTFE micropowder use, the previous 5 July 2022 review deadline sentence was removed, and a new final sentence was added limiting the 1 mg/kg threshold to manufacture, placing on the market and use of PFOA and its salts present in PTFE micropowders transported or treated to reduce PFOA concentration below 0,025 mg/kg.
In point 5, the punctuation after subpoint (d) was changed from a semicolon to a full stop.
Cited: Annex I, v1 · Annex I, v2
text before / after
02019R1021-20230610 → 02019R1021-20230818
ANNEX I
Part A
Substances listed in the Convention and in the Protocol as well as substances listed only in the Convention
Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the restriction of the use of … 2,925 unchanged words … set out in Article 18(4)(a) to (f) of that Regulation for the production of fluorochemicals with a perfluoro carbon chain equal to or shorter than 6 atoms. This exemption shall be reviewed and assessed by the Commission no later than 5.7.2022. 25 August 2023.
4. For the purposes of this entry, Article 4(1), point (b) of Article 4(1) (b), shall apply to concentrations of PFOA and its salts equal to or below 1 mg/kg (0,0001 % by weight) where they are present in polytetrafluoroethylene (PTFE) micropowders produced by ionising irradiation or by thermal degradation as well as in mixtures and articles for industrial and professional uses containing PTFE micropowders. micropowders until 18 August 2023. All emissions of PFOA during the manufacture and use of PTFE micropowders shall be avoided and, if not possible, reduced as far as possible. This exemption The limit of 1 mg/kg (0,0001 % by weight) shall be reviewed apply only to manufacture, placing on the market and assessed use of PFOA and its salts where they are present in PTFE micropowders that are transported or treated for the purpose to reduce the concentration of PFOA and its salts below the limit of 0,025 mg/kg (0,0000025 % by the Commission no later than 5.7.2022. weight).
5. By way of derogation, the manufacturing, placing on the market and use of PFOA, its salts and PFOA-related compounds shall be allowed for the following purposes:
(a) photolithography or etch processes in semiconductor manufacturing, until 4 July 2025;
(b) photographic coatings applied to films, until 4 July 2025;
(c) textiles for oil- and water-repellency for the protection of workers from dangerous liquids that comprise risks to their health and safety, until 4 July 2023;
(d) invasive and implantable medical devices, until 4 July 2025; 2025.
(e) manufacture of polytetrafluoroethylene (PTFE) and polyvinylidene fluoride (PVDF) for the production of:
(i) high-performance, corrosion-resistant gas filter membranes, water filter membranes and membranes for medical textiles;
(ii) industrial waste heat exchanger equipment,
(iii) industrial sealants capable of preventing leakage of volatile organic … 325 unchanged words … and implantable devices. This exemption shall be reviewed and assessed by the Commission no later than 22 February 2023.
Dicofol 115-32-2 204-082-0 None
Part B
Substances listed only in the Protocol
Substance CAS No EC No Specific exemption on intermediate use or other specification
The full entry, with the citation mapping v1 = 02019R1021-20230610, v2 = 02019R1021-20230818, is committed at eu/32019R1021/CHANGELOG.md.